Paula Louise Sharpe
DuPont
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Paula Louise Sharpe.
Pest Management Science | 2001
Stephen Frederick Mccann; Gary David Annis; Rafael Shapiro; David W. Piotrowski; George Philip Lahm; Jeffery K Long; Kevin C. Lee; Margaret M. Hughes; Brian James Myers; Sandra M. Griswold; Bonita M. Reeves; Robert W. March; Paula Louise Sharpe; Patrick D. Lowder; William Eldo Barnette; Keith Dumont Wing
The evolution of the insecticidal pyrazoline moiety that was originally discovered in 1972 has led to the discovery of a new crop insecticide, indoxacarb, which is the first commercialized pyrazoline-type sodium-channel blocker. Both monocyclic and fused-tricyclic pyrazolines and pyridazines, as well as structurally related semicarbazones were examined prior to the discovery of analogous tricyclic oxadiazines which had similarly high activity as well as favorable environmental dissipation rates and low toxicity to non-target organisms. The eventual leading candidate, DPX-JW062, was originally obtained as a racemic molecule, but a chiral synthesis was developed which produces material that is 50% ee in the insecticidal (+)-S-enantiomer (DPX-MP062, indoxacarb).
Bioorganic & Medicinal Chemistry | 2016
Andrew Edmund Taggi; Thomas Martin Stevenson; James Francis Bereznak; Paula Louise Sharpe; Steven Gutteridge; Robert Forman; John Joseph Bisaha; Daniel Cordova; Martina Crompton; Lora Geist; Patrick Ryan Kovacs; Eric Allen Marshall; Ritesh Bharat Sheth; Courtney Stavis; Chi-Ping Tseng
A novel class of synthetic tubulin polymerization disruptors, based on a substituted pyrazin-2-one core, has been discovered. These molecules have proven to be potent broad spectrum fungicides, with activity on agriculturally important ascomycete and basidiomycete pathogens. They have also been found to be particularly potent against human rhabdomyosarcoma cells. Using an efficient synthetic route, the agricultural and medicinal activity was explored.
Archive | 2004
Dominic Ming-Tak Chan; Balreddy Kamireddy; Jeffrey Keith Long; Kanu Maganbhai Patel; Paula Louise Sharpe
Archive | 2008
Amy X. Ding; Jeffrey Keith Long; Stephen Frederick Mccann; Paula Louise Sharpe; Andrew Edmund Taggi; Chi-Ping Tseng
Archive | 2008
John Joseph Bisaha; Alvin Donald Crews; Paula Louise Sharpe; Thomas Martin Stevenson; Andrew Edmund Taggi
Archive | 2007
James Francis Bereznak; Thomas Martin Stevenson; Paula Louise Sharpe; Andrew Edmund Taggi
Archive | 2010
Paula Louise Sharpe
Archive | 2008
Yuzhong Chen; Paula Louise Sharpe
Archive | 2015
Nicholas Ryan Deprez; Ravisekhara Pochimireddy Reddy; Paula Louise Sharpe; Thomas Martin Stevenson
Archive | 2016
Nicholas Ryan Deprez; Paula Louise Sharpe; Ravisekhara Pochimireddy Reddy; John Robbins Debergh